Quickly Spot Consensus Among the World's Best Equity Analysts

Name Upside % Analysts
bullish %
1
14,785%
upside
3 price targets
0 %
2
1,459%
upside
3 price targets
0 %
3
858%
upside
3 price targets
0 %
ATYR
4
aTyr Pharma
ATYR
$99.9M
537%
upside
3 price targets
0 %
5
529%
upside
4 price targets
0 %
6
457%
upside
5 price targets
0 %
7
431%
upside
4 price targets
0 %
8
383%
upside
3 price targets
0 %
9
355%
upside
3 price targets
0 %
10
354%
upside
5 price targets
0 %
CLYM
11
Climb Bio
CLYM
$131M
349%
upside
3 price targets
0 %
12
336%
upside
3 price targets
0 %
13
317%
upside
3 price targets
0 %
14
301%
upside
4 price targets
0 %
15
300%
upside
3 price targets
0 %
16
285%
upside
3 price targets
0 %
17
281%
upside
3 price targets
0 %
18
272%
upside
3 price targets
0 %
19
259%
upside
4 price targets
0 %
20
228%
upside
3 price targets
0 %
21
206%
upside
3 price targets
0 %
22
205%
upside
3 price targets
0 %
23
191%
upside
3 price targets
0 %
24
182%
upside
5 price targets
0 %
25
175%
upside
3 price targets
0 %